Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients-Reference-Cited by-同舟云学术

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Published:2016-05 Issue:6 Volume:15 Page:1134-1143
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Jiménez-Valerio Gabriela,Martínez-Lozano Mar,Bassani Nicklas,Vidal August,Ochoa-de-Olza María,Suárez Cristina,García-del-Muro Xavier,Carles Joan,Viñals Francesc,Graupera Mariona,Indraccolo Stefano,Casanovas Oriol

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference15 articles.

1. Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signaling;Allen;Cell Rep.,2016

2. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

3. Comprehensive molecular characterization of clear cell renal cell carcinoma;Nature,2013

4. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors;Casanovas;Cancer Cell,2005

5. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?;De Bock;Nat. Rev. Clin. Oncol.,2011

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of the response to antiangiogenic sunitinib therapy by non-invasive hybrid diffuse optics in renal cell carcinoma;Biomedical Optics Express;2024-09-06

2. Milestones in tumor vascularization and its therapeutic targeting;Nature Cancer;2024-06-25

3. The emerging role of lactate in tumor microenvironment and its clinical relevance;Cancer Letters;2024-05

4. A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling;Molecular Cancer Therapeutics;2024-04-30

5. Immunosurveillance encounters cancer metabolism;EMBO Reports;2024-01-12